HK1254867A1 - 生長激素的禁食水平作為心血管風險的預測標誌物 - Google Patents

生長激素的禁食水平作為心血管風險的預測標誌物

Info

Publication number
HK1254867A1
HK1254867A1 HK18113968.1A HK18113968A HK1254867A1 HK 1254867 A1 HK1254867 A1 HK 1254867A1 HK 18113968 A HK18113968 A HK 18113968A HK 1254867 A1 HK1254867 A1 HK 1254867A1
Authority
HK
Hong Kong
Prior art keywords
growth hormone
cardiovascular risk
predictive marker
fasting levels
fasting
Prior art date
Application number
HK18113968.1A
Other languages
English (en)
Inventor
安德里亞斯‧伯格曼
Original Assignee
斯弗因高泰克有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 斯弗因高泰克有限公司 filed Critical 斯弗因高泰克有限公司
Publication of HK1254867A1 publication Critical patent/HK1254867A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/61Growth hormones [GH] (Somatotropin)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HK18113968.1A 2013-01-08 2018-11-01 生長激素的禁食水平作為心血管風險的預測標誌物 HK1254867A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13150566 2013-01-08

Publications (1)

Publication Number Publication Date
HK1254867A1 true HK1254867A1 (zh) 2019-07-26

Family

ID=47469834

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16103237.9A HK1215302A1 (zh) 2013-01-08 2016-03-21 生長激素的禁食水平作爲心血管風險的預測標志物
HK18113968.1A HK1254867A1 (zh) 2013-01-08 2018-11-01 生長激素的禁食水平作為心血管風險的預測標誌物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16103237.9A HK1215302A1 (zh) 2013-01-08 2016-03-21 生長激素的禁食水平作爲心血管風險的預測標志物

Country Status (10)

Country Link
US (2) US20150346222A1 (zh)
EP (1) EP2943795B1 (zh)
JP (1) JP6430962B2 (zh)
CN (2) CN104937421B (zh)
CA (1) CA2897327A1 (zh)
ES (1) ES2879023T3 (zh)
HK (2) HK1215302A1 (zh)
RU (1) RU2677895C2 (zh)
SG (1) SG11201505222RA (zh)
WO (1) WO2014108396A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201702053TA (en) * 2014-10-01 2017-04-27 Sphingotec Gmbh Hgh determination for use to guide prevention of a major adverse cardiac event or a cardiovascular disease in a subject
US9921230B2 (en) * 2014-10-08 2018-03-20 Rhode Island Hospital Methods for diagnosis and treatment of concussion or brain injury
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
SG11201906939XA (en) * 2017-02-06 2019-08-27 Resiliun B V Interaction between c-peptides and elastin receptor, a model for understanding vascular disease
RU2770550C1 (ru) * 2021-05-31 2022-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования сердечно-сосудистого риска с помощью определения уровня эстрогенов

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634716B2 (en) 1988-08-01 1993-03-04 Ciba Corning Diagnostics Corp. Method for detection of an analyte using acridinium esters and liposomes
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
JP2005508623A (ja) 2001-08-30 2005-04-07 バイオレクシス ファーマシューティカル コーポレイション 改変されたトランスフェリン融合タンパク質
ES2559927T3 (es) 2002-06-07 2016-02-16 Dyax Corp. Prevención y reducción de pérdida de sangre y respuesta inflamatoria
EP1675878A2 (en) 2003-10-24 2006-07-05 Avidia, Inc. Ldl receptor class a and egf domain monomers and multimers
US20070123470A1 (en) * 2003-10-24 2007-05-31 Wladimir Hogenhuis Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue
US20100028995A1 (en) 2004-02-23 2010-02-04 Anaphore, Inc. Tetranectin Trimerizing Polypeptides
EP1793847A2 (en) 2004-09-21 2007-06-13 NascaCell IP GmbH Use of microproteins as tryptase inhibitors
WO2007124439A2 (en) * 2006-04-21 2007-11-01 Rules-Based Medicine, Inc. Diagnosis of stroke using metalloproteinase or transaminase
WO2009077175A1 (en) 2007-12-19 2009-06-25 Affibody Ab Polypeptide derived from protein a and able to bind pdgf
WO2010046136A1 (en) * 2008-10-24 2010-04-29 B.R.A.H.M.S. Ag Prognosis and risk assessment in stroke patients by determining the level of marker peptides
ES2836948T3 (es) 2008-11-03 2021-06-28 Molecular Partners Ag Proteínas de unión que inhiben la interacción del receptor de VEGF-A
NZ598351A (en) 2009-08-27 2014-08-29 Covagen Ag Il-17 binding compounds and medical uses thereof
CN102753569A (zh) 2009-12-14 2012-10-24 塞尔蛋白质股份有限公司 对纤维连接蛋白额外结构域b具有特异结合活性的修饰的泛素蛋白
CN105949301B (zh) 2010-06-08 2020-03-27 皮里斯制药有限公司 结合IL-4受体α的泪脂质运载蛋白突变蛋白

Also Published As

Publication number Publication date
EP2943795B1 (en) 2021-02-24
CN104937421B (zh) 2018-01-19
WO2014108396A1 (en) 2014-07-17
JP2016507743A (ja) 2016-03-10
CA2897327A1 (en) 2014-07-17
US20150346222A1 (en) 2015-12-03
RU2677895C2 (ru) 2019-01-22
SG11201505222RA (en) 2015-08-28
RU2015133018A (ru) 2017-02-14
JP6430962B2 (ja) 2018-11-28
ES2879023T3 (es) 2021-11-19
EP2943795A1 (en) 2015-11-18
US20200049721A1 (en) 2020-02-13
CN104937421A (zh) 2015-09-23
HK1215302A1 (zh) 2016-08-19
CN107991501A (zh) 2018-05-04

Similar Documents

Publication Publication Date Title
HK1203783A1 (zh) 鞋帶卷取用卷盤
HK1222860A1 (zh) 作爲葛瑞林 -酰基轉移酶抑制劑的被取代的哌啶基-乙基-嘧啶
HK1254867A1 (zh) 生長激素的禁食水平作為心血管風險的預測標誌物
EP2970081A4 (en) SALTS OF TREPROSTINIL
EP2979568A4 (en) INDOOR SPORTS SHOE
LT3003866T (lt) Dozatoriaus gamybos būdas
HK1218728A1 (zh) 抑制骨質疏鬆的治療劑
GB2535880B (en) Two-part set-delayed cement compositions
GB2515071B (en) Novel composition for a foot-soaking bath
HRP20180722T1 (hr) Spoj benzotiofena
ZA201504931B (en) New antifungal compositions
IL230063A0 (en) A technique to control selection order
GB2509746B (en) Method of manufacture of a container
GB201308321D0 (en) Top marker
GB2511764B (en) Pole for show jumping
AU2013245V (en) Bondrelaipi Xerochrysum bracteatum
AU2013244V (en) Bondrepuho Xerochrysum bracteatum
AU2013243V (en) Bondreredem Xerochrysum bracteatum
GB201312761D0 (en) A composition
GB201311648D0 (en) A novel glass-lonomer cement
GB201314379D0 (en) Novel target
GB201314389D0 (en) Novel target
GB201308441D0 (en) Automatic placement markers